动脉粥样硬化与基质金属蛋白酶

被引:33
作者
任冰稳
机构
[1] 西安交通大学第一医院心内科陕西省西安市
关键词
金属蛋白酶类; 细胞外基质; 动脉粥样硬化;
D O I
暂无
中图分类号
R543.5 [动脉疾病];
学科分类号
摘要
动脉粥样硬化 (AS)形成过程也是细胞外基质重构的过程。基质金属蛋白酶 (MMPs)是降解细胞外基质最重要的酶类。怎样适度调节MMPs的活性引起了人们的重视。近年来人们对MMPs的结构功能、活性调节及在AS中的作用有了初步的了解。本文就这方面的结果作一综述。
引用
收藏
页码:74 / 75
页数:2
相关论文
共 10 条
[1]  
Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Fukumoto Y,Libby P,Rabkin E. Circulation . 2001
[2]  
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. Bocan TM,Krause BR,Rosebury WS,et al. Arteriosclerosis and Thrombosis . 2000
[3]  
Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis.Implications for plaque rupture. Lee RT,Schoen FJ,Loree HM,et al. Arteriosclerosis and Thrombosis . 1996
[4]  
Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Rajavashisth TB,Xu XP,Jovinge S. Circulation . 1999
[5]  
Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques. Sukhova GK,Schonbeck U,Rabkin E,et al. Circulation . 1999
[6]  
Tissue inhibitors of metalloproteinases:evolution, structure and function. Brew K,Dinakarpandian D,Nagase H. Biochimica et Biophysica Acta . 2000
[7]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[8]  
Activation mechanisms of matrix metalloproteinases. Nagase H. Biological Chemistry . 1997
[9]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[10]  
Tissure inhibitor of matrix metalloproteinase-1 impairs arterial neointima formation after vascular injure in mice. Lijinen HR,Soloway P,Collen D. Circulation Research . 1999